Dr. Ranjana Advani, MD
- Medicare services, 2024
- 304
- Medicare patients, 2024
- 158
- Part D claims, 2024
- 33
- Publications
- 230
- Clinical trials
- 20
- Practice address
- 300 Pasteur Drive, Stanford, CA 94305
- Practice phone
- Call (650) 723-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Advani's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Ranjana Advani is a medical oncologist in Stanford, California
Dr. Advani practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.
Dr. Advani's NPI, 1639225121, was assigned on January 26, 2007. Dr. Advani graduated from Grant Medical College in 1983. Dr. Advani's California license number on file is A44422.
- NPI
- 1639225121NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0547333551
- NPI enumeration date
- January 26, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (650) 723-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 70
- Medical school graduation
- 1983
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Ranjana Advani practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California
Dr. Advani's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.
- Stanford Hospital at 300 Pasteur Drive300 Pasteur Drive, Stanford, CA 94305 · Santa Clara CountyPhone(650) 723-4000
Source: Dmand AI Affiliation Data
Dr. Ranjana Advani is affiliated with 2 sites of care and 1 medical group
Dr. Advani's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Advani to 1 more hospital, named with a free account. Dr. Advani's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Ranjana Advani's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Advani practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Stanford Hospital at 300 Pasteur Drive | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Stanford University and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Ranjana Advani is one of 415 medical oncologists in California
Medical oncology is Dr. Advani's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Advani is board certified in medical oncology by the American Board of Internal Medicine. Dr. Advani has a license on file in California.
Specialties and state licenses
- Medical oncology, CaliforniaPrimary
Clinical focus
Dmand AI lists chronic anemia, chronic leukemia, lymphoma and prostate cancer among the conditions Dr. Advani treats.
Medical oncologists near Dr. Advani
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Ranjana Advani billed Medicare for 304 services in 2024
CMS data shows 304 Medicare services from Dr. Advani across 4 procedure codes in 2024, all of them office visits, for 158 Medicare patients. Medicare paid $31,509 for them.
Dr. Advani's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3192024: 3045%
Where Dr. Advani's Medicare services took place, 2024
- In an office8327%
- In a facility22173%
Dr. Advani compared with the California median for medical oncologists, 2024
- Dr. Advani
- California median
- Medicare services
- 304vs 49639% below
- Medicare patients
- 158vs 154Close to median
- Part D claims
- 11vs 14492% below
Medians across 358 medical oncologists in California with Dmand AI profiles that report each measure.
Dr. Advani's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Advani?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Advani and other medical oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Ranjana Advani treated 158 Medicare patients in 2024, average age 74
CMS counts 158 Medicare patients who saw Dr. Advani in 2024. The largest group is 75 to 84, with 68 patients. 66% of them have high cholesterol, and 54% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Advani's median patient age at 58, with 50% women.
Dr. Advani's Medicare patients by age, 2024
Dr. Advani's Medicare patients by sex, 2024
- Women6642%
- Men9258%
Chronic conditions among Dr. Advani's Medicare patients, 2024
- High cholesterol66%
- High blood pressure54%
- Arthritis37%
- Ischemic heart disease25%
- Diabetes22%
- Atrial fibrillation20%
- Cancer18%
- Osteoporosis17%
Share of Medicare patients with each condition. A patient can have several.
Dr. Advani's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 58
Patient panel by sex, all payers
- Women50%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Ranjana Advani wrote 33 Medicare Part D claims in 2024
In 2024, Dr. Advani wrote 33 Medicare Part D claims. 45% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $152 in total drug cost. In 2021, CMS named 12 claims across 1 drug.
Dr. Advani's Part D claims by kind of drug, 2024
- Generic15 claims45%
- Brand-name18 claims55%
Dr. Advani's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 122022: 118%
Drugs named by CMS: 1 in 2022, 1 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Ranjana Advani scored 89 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Advani for performance year 2024, reported as part of a group. Dr. Advani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Advani as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Advani's MIPS scores, performance year 2024
- 89of 100Final score
- 87.1of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 70of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Ranjana Advani has 230 publications on record
Dmand AI links 230 papers to Dr. Advani, published from 2003 to 2025. 2016 was the busiest year, with 15. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Hodgkin Disease and Doxorubicin. Dr. Advani has published most often in Blood. Dr. Advani's most frequent co-authors are Richard Thomas Hoppe, MD, Nancy Lee Bartlett, MD and Brad Steven Kahl, MD.
Dr. Advani's papers by year, 2016 to 2025
Topics Dr. Advani writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Hodgkin Disease
- Doxorubicin
- Lymphoma, Large B-Cell, Diffuse
- Rituximab
- Brentuximab Vedotin
- Immunoconjugates
- Vincristine
Dr. Advani's most frequent co-authors
- Richard Thomas Hoppe, MD43 shared papers
- Nancy Lee Bartlett, MD34 shared papers
- Brad Steven Kahl, MD23 shared papers
Recent publications by Dr. Advani
Pediatr Blood Cancer
See who Dr. Advani researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Advani works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Ranjana Advani has worked on 20 clinical trials
Dmand AI links Dr. Advani to 20 clinical trials, 12 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma and Immunoblastic Lymphadenopathy. Seagen Inc. sponsors the most, 5. Open Payments lists research payments to Dr. Advani that name 1 trial.
Clinical trials with Dr. Advani by phase
- 1Phase 1: 1 trial
- 3Phase 1/2: 3 trials
- 12Phase 2: 12 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Advani's trials
- Hodgkin Disease
- Lymphoma
- Immunoblastic Lymphadenopathy
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, T-Cell
Investigators on the most trials with Dr. Advani
- Stephen M. Ansell, MD6 shared trials
- Nancy Lee Bartlett, MD4 shared trials
- Andres Forero-Torres, MD4 shared trials
Recent clinical trials with Dr. Advani
Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma (opens in a new tab)
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma (opens in a new tab)
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma (opens in a new tab)
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Ranjana Advani received $182,642 in industry payments from 2016 to 2025
CMS Open Payments shows 157 general payments to Dr. Advani from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Genentech, Inc. paid the most, $48,364. It also lists 29 research payments totaling $33,408 from 2016 to 2025, naming 1 clinical trial.
General payments to Dr. Advani by program year, 2016 to 2025
General payments to Dr. Advani by kind, 2016 to 2025
- Consulting fees$123,09767%
- Travel and lodging$33,72418%
- Speaker and faculty fees$14,8278%
- Honoraria$7,9884%
- Other$3,0062%
Companies that paid Dr. Advani the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Ranjana Advani has 1 award and honors on record
Dmand AI lists 1 award for Dr. Advani, most recently CMS Stage 1 EHR in 2013. Dr. Advani serves on Committee on Appropriateness Criteria Expert Panel on Radiation Oncology - Lymphoma American College of Radiology.
Awards and honors for Dr. Advani
- 2013
- CMS Stage 1 EHR
Dr. Advani's committees and leadership roles
- Committee on Appropriateness Criteria Expert Panel on Radiation Oncology - Lymphoma American College of RadiologyMember
- 2015 to present
Source: Dmand AI Professional Profile Data
Dr. Ranjana Advani graduated from Grant Medical College
Dr. Advani graduated from Grant Medical College in 1983. Dr. Advani is a member of ASCO.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Ranjana Advani accepts plans from 9 insurance carriers
Dr. Advani is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- United Healthcare
- Blue Cross and Blue Shield of Kansas City
- +1 more carriersWith a free account
Plan types Dr. Advani accepts, by number of carriers
- Medicare7
- PPO6
- HMO4
- POS4
- EPO3
Source: Dmand AI Insurance Network Data
Sources for Dr. Ranjana Advani's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Ranjana Advani
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Ranjana Advani's NPI number?
Dr. Ranjana Advani's NPI number is 1639225121. It was assigned on January 26, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Ranjana Advani?
Dr. Ranjana Advani is a medical oncologist in Stanford, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Ranjana Advani practice?
Dr. Advani practices at 300 Pasteur Drive, Stanford, CA 94305. Dr. Advani's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dmand AI also links Dr. Advani to 1 hospital.
What is Dr. Ranjana Advani's office phone number?
The practice phone on file for Dr. Advani is (650) 723-4000.
What is Dr. Ranjana Advani's medical license number?
Dr. Advani's California license number on file is A44422.
Which hospitals is Dr. Ranjana Advani affiliated with?
Dr. Advani practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California. Dmand AI links Dr. Advani to 1 more hospital.
What medical group is Dr. Ranjana Advani part of?
Dr. Advani is linked to Stanford Health Care.
Does Dr. Ranjana Advani accept Medicare?
Yes. CMS data shows Dr. Advani billed Medicare for 304 services in 2024, and Dr. Advani accepts Medicare assignment.
Does Dr. Ranjana Advani offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Advani as offering telehealth services.
What is Dr. Ranjana Advani's MIPS score?
Dr. Advani's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Ranjana Advani see?
CMS counts 158 Medicare patients who saw Dr. Advani in 2024, with an average age of 74.
Is Dr. Ranjana Advani board certified?
Yes. Dr. Advani is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Ranjana Advani bill to Medicare?
In 2024, Dr. Advani's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and office visit, established patient (99213).
Where did Dr. Ranjana Advani go to medical school?
Dr. Advani graduated from Grant Medical College in 1983.
What drugs does Dr. Ranjana Advani prescribe most?
In 2022 Medicare Part D data, Dr. Advani's most prescribed drugs by claims were Famotidine.
Has Dr. Ranjana Advani received payments from drug or device companies?
CMS Open Payments shows $182,642 in general payments to Dr. Advani from 23 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Ranjana Advani been practicing?
Dr. Advani graduated from medical school in 1983, 43 years ago.
Does Dr. Ranjana Advani do research?
Dmand AI links 230 publications to Dr. Advani, published from 2003 to 2025. Dr. Advani has worked on 20 clinical trials.
Who does Dr. Ranjana Advani publish with?
Dr. Advani's most frequent co-authors are Richard Thomas Hoppe, MD (43 shared papers), Nancy Lee Bartlett, MD (34 shared papers) and Brad Steven Kahl, MD (23 shared papers).
What insurance does Dr. Ranjana Advani accept?
Dr. Advani is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card